"Parkinsonian Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Descriptor ID |
D020734
|
| MeSH Number(s) |
C10.228.140.079.862 C10.228.662.600
|
| Concept/Terms |
Parkinsonian Disorders- Parkinsonian Disorders
- Parkinsonian Syndrome
- Parkinsonism
- Parkinsonian Syndromes
- Parkinsonian Diseases
Autosomal Recessive Juvenile Parkinson Disease- Autosomal Recessive Juvenile Parkinson Disease
- Chromosome 6-Linked Autosomal Recessive Parkinsonism
- Chromosome 6 Linked Autosomal Recessive Parkinsonism
- Familial Parkinson Disease, Autosomal Recessive
- Juvenile Parkinson Disease, Autosomal Recessive
- Juvenile Parkinsonism, Autosomal Recessive
- Parkinsonism, Early Onset, with Diurnal Fluctuation
- Parkinsonism, Juvenile, Autosomal Recessive
- Parkinson Disease 2, Autosomal Recessive Juvenile
- Parkinsonism, Early-Onset, With Diurnal Fluctuation
- Parkinson Disease, Juvenile, Autosomal Recessive
- Parkinson Disease 2
- Parkinson Disease Autosomal Recessive, Early Onset
- Autosomal Recesssive Juvenile Parkinsonism
- Parkinson Disease, Familial, Autosomal Recessive
Parkinsonism, Experimental- Parkinsonism, Experimental
- Experimental Parkinsonisms
- Parkinsonisms, Experimental
- Parkinson Disease, Experimental
- Experimental Parkinsonism, MPTP-Induced
- Experimental Parkinsonism, MPTP Induced
- Parkinsonism, MPTP-Induced Experimental
- MPTP-Induced Experimental Parkinsonism
- MPTP Induced Experimental Parkinsonism
- Experimental Parkinson Disease
- Diseases, Experimental Parkinson
- Experimental Parkinson Diseases
- Parkinson Diseases, Experimental
- Experimental Parkinsonism
Parkinsonism, Juvenile- Parkinsonism, Juvenile
- Juvenile Parkinsonism
- Juvenile Parkinsonisms
- Parkinsonisms, Juvenile
- Parkinson Disease, Juvenile
- Juvenile Parkinson Disease
Autosomal Dominant Juvenile Parkinson Disease- Autosomal Dominant Juvenile Parkinson Disease
- Juvenile Parkinson Disease, Autosomal Dominant
- Parkinsonism, Juvenile, Autosomal Dominant
- Parkinson Disease, Autosomal Dominant. Juvenile
- Parkinson Disease, Juvenile, Autosomal Dominant
- Autosomal Dominant Juvenile Parkinsonism
- Juvenile Parkinsonism, Autosomal Dominant
|
Below are MeSH descriptors whose meaning is more general than "Parkinsonian Disorders".
Below are MeSH descriptors whose meaning is more specific than "Parkinsonian Disorders".
This graph shows the total number of publications written about "Parkinsonian Disorders" by people in this website by year, and whether "Parkinsonian Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 3 | 0 | 3 |
| 2010 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parkinsonian Disorders" by people in Profiles.
-
Intenzo C, Colarossi D. Invited Commentary: Molecular Imaging of Parkinsonian Syndromes. Radiographics. 2024 02; 44(2):e230233.
-
Smeyne RJ, Eells JB, Chatterjee D, Byrne M, Akula SM, Sriramula S, O'Rourke DP, Schmidt P. COVID-19 Infection Enhances Susceptibility to Oxidative Stress-Induced Parkinsonism. Mov Disord. 2022 07; 37(7):1394-1404.
-
Oakes HV, McWethy D, Ketchem S, Tran L, Phillips K, Oakley L, Smeyne RJ, Pond BB. Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism. Neurotox Res. 2021 Jun; 39(3):667-676.
-
Kostuk EW, Cai J, Iacovitti L. Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture. Glia. 2019 08; 67(8):1542-1557.
-
Olsson B, Portelius E, Cullen NC, Sandelius ?, Zetterberg H, Andreasson U, H?glund K, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk D, McCluskey L, Elman L, Shaw LM, Toledo JB, McBride J, Hernandez-Con P, Lee VM, Trojanowski JQ, Blennow K. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. JAMA Neurol. 2019 03 01; 76(3):318-325.
-
Chang RS, Poon WS. "Triggers" for referral to neurology palliative care service. Ann Palliat Med. 2018 Jul; 7(3):289-295.
-
Isaacson SH, Fisher S, Gupta F, Hermanowicz N, Kremens DE, Lew MF, Marek K, Pahwa R, Russell DS, Seibyl J. Clinical utility of DaTscan? imaging in the evaluation of patients with parkinsonism: a US perspective. Expert Rev Neurother. 2017 03; 17(3):219-225.
-
Chang RS, Leung CY, Leong HS. Bilateral Striatopallidodentate Calcinosis associated with Systemic Lupus Erythematosus: Case report and review of literature. J Neurol Sci. 2015 Nov 15; 358(1-2):518-9.
-
Peeraully T. Multiple system atrophy. Semin Neurol. 2014 Apr; 34(2):174-81.
-
Pattarini R, Rong Y, Shepherd KR, Jiao Y, Qu C, Smeyne RJ, Morgan JI. Long-lasting transcriptional refractoriness triggered by a single exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine. Neuroscience. 2012 Jul 12; 214:84-105.